Polyvascular Atherothrombotic Disease: An Enemy With Many Faces;La enfermedad polivascular aterotrombótica: un enemigo común y distintos frentes

Revista Espanola de Cardiologia Suplementos

Volumn 9, Issue 4, 2009, Pages 4-10

  Aguiar Souto, Pablo ^a   Cabanas Grandío, Pilar ^a   González Juanatey, José Ramón ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Atherosclerosis; Atherothrombosis; Cerebrovascular disease; Ischemic heart disease; Peripheral arterial disease

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PROGNOSIS; THROMBOSIS;

EID: 74549133464     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1131-3587(09)73284-4     Document Type: Article

References (31)

1. Cupples L.A., Gagnon D.R., Wong N.D., Ostfeld A.M., and Kannel W.B. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study. Am Heart J 125 (1993) 863-872
2. Yan A.T., Steg P.G., Fitzgerald G., Feldman L.J., Eagle K.A., Gore J.M., et al., For the GRACE Investigators. Recurrent ischemia across the spectrum of acute coronary syndromes: Prevalence and prognostic significance of (Re-)infarction and ST-segment changes in a large contemporary registry. Int J Cardiol (2009) [Epub ahead of print]
3. Steg P.G., Bhatt D.L., Wilson P.W., D'Agostino Sr. R., Ohman E.M., Röther J., et al., REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007) 1197-1206
4. Mostaza J.M., Manzano L., Suárez C., Cairols M., Ferreira E.M., Rovira E., et al. Prevalence of asymptomatic peripheral artery disease detected by the ankle-brachial index in patients with cardiovascular disease. MERITO II study. Med Clin (Barc) 131 (2008) 561-565
5. Grand A., Termoz A., Fichter P., Ghadban W., Velon S., Abdulrahman O., et al. Myocardial infarction in the elderly. Comparison between 2 groups of patients over 75 and under 65 years of age. Ann Cardiol Angeiol (Paris) 46 (1997) 561-567
6. Bertomeu V., Morillas P., González-Juanatey J.R., Quiles J., Guindo J., Soria F., et al. Prevalence and prognostic influence of peripheral arterial disease in patients ≥ 40 years old admitted into hospital following an acute coronary event. Eur J Vasc Endovasc Surg 36 (2008) 189-196
7. Morillas P., Cordero A., Bertomeu V., González-Juanatey J.R., Quiles J., Guindo J., et al. Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens 27 (2009) 341-347
8. Khoury Z., Schwartz R., Gottlieb S., Chenzbraun A., Stern S., and Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 80 (1997) 1429-1433
9. Kannel W.B., Wolf P.A., and Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 250 (1983) 2942-2946
10. Leys D. Atherothrombosis: a major health burden. Cerebrovasc Dis 11 (2001) 1-4
11. Caicoya M., Corrales C., Laceras C., Cuello R., and Rodríguez T. Asociación entre accidente cerebrovascular y enfermedad arterial periférica: estudio de casos y controles en Asturias, España. Rev Clin Esp 195 (1995) 830-835
12. House A.K., Bell R., House J., Mastaglia F., Kumart A., and Antuono M. Asymptomatic carotid artery stenosis associated with peripheral vascular disease: a prospective study. Cardiovasc Surg 7 (1999) 44-49
13. Simons P.C.G., Algra A., Eikelboom B.C., Grobbee D.E., Van der Graaf Y., and For the SMART study group. Carotid artery stenosis in patients with peripheral arterial disease: The SMART. J Vasc Surg 30 (1999) 519-525
14. Hooi J.D., Stoffers H.E.J.H., Kester A.D.M., Rinkens P.E.L.M., Kaiser V., Van Ree J.W., et al. Risk factors and cardiovascular disease associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Scand J Prim Health Care 16 (1998) 177-182
15. Zheng Z.J., Sharrett A.R., Chambless L.E., Rosamond W.D., Nieto F.R., Sheps D.S., et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis; the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 131 (1997) 115-125
16. Bots M.L., Hofman A., and Grobbee D.E. Common carotid intimamedia thickness and lower extremity arterial atherosclerosis. Arterioscler Thromb 14 (1994) 1885-1891
17. Criqui M.H., and Denenberg J.O. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 3 (1998) 241-245
18. Meijer W.T., Hoes A.W., Rutgers A.D., Bots M.L., Hofman A., and Grobbee D.E. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 18 (1998) 185-192
19. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelmark M., Polak J.E., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 19 (1999) 539-545
20. Criqui M.H., Fronek A., Barrett-Connor E., Klauber M.R., Gabriel S., and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985) 510-515
21. Newman A.B., Siscovick D.S., Manolio T.A., Polak J., Fried L.P., Borhani N.O., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993) 837-845
22. Poredos P., and Jug B. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 58 (2007) 309-315
23. Ness J., and Aronow W.S. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospitalbased geriatrics practice. J Am Geriatr Soc 47 (1999) 1255-1256
24. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
25. Mostaza J.M., González-Juanatey J.R., Castillo J., Lahoz C., Fernández-Villaverde J.M., and Maestro-Saavedra F.J. Prevalence of carotid stenosis and silent myocardial ischemia in asymptomatic subjects with a low ankle-brachial index. J Vasc Surg 49 (2009) 104-108
26. Bosch J., Yusuf S., Pogue J., Sleight P., Lonn E., Rangoonwala B., et al., HOPE Investigators. Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: double blind randomised trial. BMJ 324 (2002) 699-702
27. Yusuf S., Teo K.K., Pogue J., Dyal L., Copland I., Schumacher H., et al., ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358 (2008) 1547-1559
28. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of colesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
29. Johnson C., Waters D.D., DeMicco D.A., Breazna A., Bittner V., Greten H., et al. Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study). Am J Cardiol 15 102 (2008) 1312-1317
30. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
31. Belch J., MacCuish A., Campbell I., Cobbe S., Taylor R., Prescott R., et al., Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337 (2008) a1840